Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Treasury Shares (2016 - 2025)

Iradimed (IRMD) has disclosed Treasury Shares for 10 consecutive years, with $82792.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 38.48% to $82792.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $82792.0 through Dec 2025, down 38.48% year-over-year, with the annual reading at $82792.0 for FY2025, 38.48% down from the prior year.
  • Treasury Shares for Q3 2017 was $1.8 million at Iradimed, up from $1.6 million in the prior quarter.
  • The five-year high for Treasury Shares was $134580.0 in Q4 2024, with the low at $27884.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $82646.0, with a median of $82792.0 recorded in 2025.
  • Peak annual rise in Treasury Shares hit 81.76% in 2017, while the deepest fall reached 84.42% in 2017.
  • Over 2 years, Treasury Shares stood at $10.0 million in 2016, then crashed by 81.76% to $1.8 million in 2017.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $82792.0, $134580.0, and $36792.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.